2026 NPPES data Ophthalmology Physician NPI 1174539266 M.D.
Verify on CMS →

MARK REMINGTON, M.D.

Ophthalmology Physician in KALISPELL, Montana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
911
Medicare Part D claims · 327 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
62%
generic claims · 38% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
95.3555/100
▲ 12 pts above national avg 83.1 · [object Object]
Industry payments
$15.65
1 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MARK REMINGTON, M.D. is a Ophthalmology Physician ([object Object]) practicing in KALISPELL, Montana with a Medicare Part D prescribing footprint of 911 claims across 327 beneficiaries — 38% brand-name prescribing . Their CMS MIPS Final Score of 95.3555/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $15.65 across 1 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MARK REMINGTON, M.D. reported a CMS MIPS final score of 95.3555 out of 100, above the 83.1 national average, and filed 911 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MARK REMINGTON, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MARK REMINGTON, M.D. at a glance

High performer (top quartile)

NPI registry status

Active

Issued 07/31/2006

NPI 1174539266

Primary specialty

Ophthalmology Physician

Mid-sized

22,090 US NPIs in this specialty

Medicare Part D claims

911 36% vs specialty avg

2023 prescription claims

Specialty avg: 1,420

MIPS final score

95.3555/100 12.255500000000012% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Montana

How Ophthalmology Physician compares to other specialties among Montana providers

Montana providers

Ophthalmology Physician share within Montana

1. Ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmology Physician share within Montana

Medicare quality performance — MIPS

MARK REMINGTON, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average

High performer (top quartile)
MIPS Final Score
95.3555/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Ophthalmology Physician) — 95.3555/100 vs national avg 83.1

0%100%National avg83%95.4%
MIPS final score (Ophthalmology Physician) — 95.3555/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK REMINGTON, M.D. is a Ophthalmology Physician provider practicing in KALISPELL, Montana, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1174539266. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK REMINGTON, M.D. appears in the CMS NPPES registry as a Ophthalmology Physician provider holding M.D. credentials at 175 TIMBERWOLF PKWY, KALISPELL, MT, 59901, with a listed phone of (406) 257-2020. NPI 1174539266 was issued on 07/31/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what REMINGTON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 911 prescription claims written by this provider, covering 327 Medicare beneficiaries and totaling roughly $55K in drug spend, split 38% brand-name and 62% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 95.3555/100 for the 2023 performance year (Quality 100, Cost 84.5183), compared with the national average of 83.1.

Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

175 TIMBERWOLF PKWY
KALISPELL, MT 59901

Provider Details

NPI 1174539266
Specialty Ophthalmology Physician
Credentials M.D.
Gender Male
NPI Issued 07/31/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

95.3555
Final Score
Avg: 83.1
100
Quality
84.5183
Cost

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK REMINGTON, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$16

Largest payer

Johnson & Johnson Surgical Vision, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

MARK REMINGTON, M.D. — brand share 38.0%
Specialty average (est.)

38% brand-name claims vs 62% generic, on 911 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

911
Total Claims
$55K
Total Drug Cost
327
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,460
Total Day Supply
40,704
Brand vs Generic
38% brand / 62% generic
Brand Drug Cost
$43K
Generic Drug Cost
$12K

Patient Demographics

Average Patient Age
74.4 years
Avg HCC Risk Score
0.99
Gender Split
55% female / 45% male
Age Distribution
<65: 12, 65-74: 177, 75-84: 104, 85+: 34

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Prednisolone Acetate
274
Ofloxacin
228
Latanoprost
156
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
64
Timolol Maleate
34
Bacitracin-Polymyxin
Bacitracin/Polymyxin B Sulfate
26
Brimonidine Tartrate
26
Erythromycin
Erythromycin Base
21
Restasis
Cyclosporine
15
Dorzolamide Hcl
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmology Physician Overview

How MARK REMINGTON, M.D. fits within the Ophthalmology Physician landscape nationally.

22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider

MARK REMINGTON, M.D.'s 911 claims are below the specialty average of 1,420.

Nearby Ophthalmology Physician Providers in Montana

Other clinicians with the same primary specialty enrolled in Montana, drawn from the same CMS NPPES roster as REMINGTON.

Compare Ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK REMINGTON, M.D.'s specialty?
MARK REMINGTON, M.D. specializes in Ophthalmology Physician and practices in KALISPELL, Montana. Credentials: M.D..
How much does MARK REMINGTON, M.D. prescribe under Medicare Part D?
In 2023, MARK REMINGTON, M.D. wrote 911 Medicare Part D claims totaling $55K in drug costs for 327 beneficiaries.
What is MARK REMINGTON, M.D.'s Medicare quality score?
MARK REMINGTON, M.D. has a CMS MIPS Final Score of 95.3555/100 (Quality: 100, Cost: 84.5183). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK REMINGTON, M.D. located?
MARK REMINGTON, M.D. is located at 175 TIMBERWOLF PKWY, KALISPELL, MT, 59901. Phone: (406) 257-2020.
What is MARK REMINGTON, M.D.'s NPI number?
MARK REMINGTON, M.D.'s National Provider Identifier (NPI) is 1174539266, issued on 07/31/2006.
Does MARK REMINGTON, M.D. prescribe more brand-name or generic drugs?
MARK REMINGTON, M.D.'s prescribing is 38% brand-name and 62% generic drugs by claim count, with $43K in brand drug costs.
How many Ophthalmology Physician providers are there in the US?
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does MARK REMINGTON, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK REMINGTON, M.D.'s most frequently prescribed drugs include Prednisolone Acetate, Ofloxacin, Latanoprost. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK REMINGTON, M.D. accept Medicare?
MARK REMINGTON, M.D. appears in CMS Medicare data with 911 Part D claims and 327 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK REMINGTON, M.D.'s credentials?
MARK REMINGTON, M.D.'s NPI is 1174539266 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology